Evidence map›Paper›PMID 25186767›Full record

ArticleScientific reports2014

Anomalous altered expressions of downstream gene-targets in TP53-miRNA pathways in head and neck cancer.

Sanga Mitra, Nupur Mukherjee, Smarajit Das, Pijush Das, Chinmay Kumar Panda, Jayprokas Chakrabarti

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Sanga MitraComputational Biology Group, Indian Association for the Cultivation of Science, Kolkata, India.
Nupur MukherjeeDepartment of Oncogene Regulation, Chittaranjan National Cancer Research Institute, Kolkata, India.
Smarajit DasDepartment of Medical Biochemistry and Cell Biology, Institute of Biomedicine, University of Gothenburg, Sweden.
Pijush DasCancer Biology &Inflammatory Disorder Division, Indian Institute of Chemical Biology, Kolkata, India.
Chinmay Kumar PandaDepartment of Oncogene Regulation, Chittaranjan National Cancer Research Institute, Kolkata, India.
Jayprokas Chakrabarti1] Computational Biology Group, Indian Association for the Cultivation of Science, Kolkata, India [2] Gyanxet, BF 286 Salt Lake, Kolkata, India.
Chittaranjan National Cancer Institute · INIndian Association for the Cultivation of Science · INIndian Institute of Chemical Biology · INUniversity of Gothenburg · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prevalence of head and neck squamous cell carcinoma, HNSCC, continues to grow. Change in the expression of TP53 in HNSCC affects its downstream miRNAs and their gene targets, anomalously altering the expressions of the five genes, MEIS1, AGTR1, DTL, TYMS and BAK1. These expression alterations follow the repression of TP53 that upregulates miRNA-107, miRNA- 215, miRNA-34 b/c and miRNA-125b, but downregulates miRNA-155. The above five so far unreported genes are the targets of these miRNAs. Meta-analyses of microarray and RNA-Seq data followed by qRT-PCR validation unravel these new ones in HNSCC. The regulatory roles of TP53 on miRNA-155 and miRNA-125b differentiate the expressions of AGTR1 and BAK1in HNSCC vis-à-vis other carcinogenesis. Expression changes alter cell cycle regulation, angiogenic and blood cell formation, and apoptotic modes in affliction. Pathway analyses establish the resulting systems-level functional and mechanistic insights into the etiology of HNSCC.

Indexed as

bcl-2 Homologous Antagonist-Killer ProteinCarcinogenesisCarcinoma, Squamous CellCell Line, TumorDatabases, GeneticDiscriminant AnalysisHead and Neck NeoplasmsHumansMicroRNAsMutationOligonucleotide Array Sequence AnalysisProto-Oncogene Proteins c-aktReal-Time Polymerase Chain ReactionReceptor, Angiotensin, Type 1RNA, MessengerSequence Analysis, RNAAGTR1 protein, humanBAK1 protein, humanbcl-2 Homologous Antagonist-Killer ProteinMicroRNAsProto-Oncogene Proteins c-aktReceptor, Angiotensin, Type 1RNA, MessengerTP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID25186767
PMCPMC5385823
OpenAlexW2040876475

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.